KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 145 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $8,605,000 | -45.3% | 114,773 | -45.1% | 0.00% | -40.0% |
| Q2 2015 | $15,738,000 | +414.7% | 208,968 | +242.6% | 0.01% | – |
| Q1 2015 | $3,058,000 | +467.3% | 60,995 | +292.7% | 0.00% | – |
| Q4 2014 | $539,000 | -50.6% | 15,534 | -53.3% | 0.00% | – |
| Q3 2014 | $1,090,000 | +121.1% | 33,286 | +158.9% | 0.00% | – |
| Q2 2014 | $493,000 | +40.5% | 12,858 | +45.7% | 0.00% | – |
| Q1 2014 | $351,000 | – | 8,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,382,722 | $69,344,000 | 3.43% |
| Versant Venture Management, LLC | 70,376 | $3,529,356,000 | 3.10% |
| AlpInvest Partners B.V. | 29,731 | $1,491,000 | 2.79% |
| Partner Investment Management, L.P. | 29,178 | $1,463,000 | 2.20% |
| PFM Health Sciences, LP | 1,242,509 | $62,312,000 | 1.72% |
| Aureus Asset Management, LLC | 130,307 | $6,535,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 444,999 | $22,317,000 | 1.49% |
| HealthCor Management, L.P. | 425,000 | $21,314,000 | 1.02% |
| Redmile Group, LLC | 225,062 | $11,287,000 | 1.01% |
| REGENTATLANTIC CAPITAL LLC | 174,454 | $8,749,000 | 0.77% |